Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

Anthera Pharmaceuticals, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States


Exchange/Ticker: Nasdaq: ANTH


Company Description

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF. Its other product candidate includes varespladib and varespladib sodium, which provides treatment for the patients who have acute coronary syndrome and acute chest syndrome associated with sickle cell disease. Anthera Pharmaceuticals was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA.

Similar to: NPS Pharmaceuticals, Inc., Trius Therapeutics, Inc., Sanofi

Featured Company


Aben Resources Ltd.

Vancouver, BC, CA

Aben Resources (TSX.V: ABN) is a Canadian gold and silver exploration company with a focus on developing properties in the Yukon.… Learn more →

You may also be interested in:


Sanofi

Paris, FR

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’… Learn more →

Trius Therapeutics, Inc.

San Diego, CA, US

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics… Learn more →

NPS Pharmaceuticals, Inc.

Bedminster, NJ, US

NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs… Learn more →